Ticker Details
Savara Inc. Savara Inc is a pharmaceutical company. The company develops novel therapies for the treatment of serious or life-threatening rare respiratory diseases.
IPO Date:	March 11, 2013
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.31B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.14 | 3.66%
Avg Daily Range (30 D):	$0.11 | 2.06%
Avg Daily Range (90 D):	$0.16 | 2.89%

Institutional Daily Volume
Avg Daily Volume:	.48M
Avg Daily Volume (30 D):	1.44M
Avg Daily Volume (90 D):	1.25M

Trade Size
Avg Trade Size (Sh.):	164
Avg Trade Size (Sh.) (30 D):	94
Avg Trade Size (Sh.) (90 D):	88

Institutional Trades
Total Institutional Trades:	655
Avg Institutional Trade:	$1.62M
Avg Institutional Trade (30 D):	$2.42M
Avg Institutional Trade (90 D):	$1.82M
Avg Institutional Trade Volume:	.36M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.82M
Avg Closing Trade (30 D):	$2.55M
Avg Closing Trade (90 D):	$1.87M
Avg Closing Volume:	384.81K

News

Jun 8, 2026 @ 8:05 PM Savara Announces Chief Financial and Administrativ... Source: Business Wire

May 27, 2026 @ 8:05 PM Savara Announces Participation in the 2026 Jefferi... Source: Business Wire

May 11, 2026 @ 8:05 PM Savara Announces Participation in the H.C. Wainwri... Source: Business Wire

Mar 6, 2026 @ 9:05 PM Savara Provides Regulatory Update on the MOLBREEVI... Source: Business Wire

Mar 4, 2026 @ 9:05 PM Savara Announces Participation in 2026 Citizens Li... Source: Business Wire

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.15	$-.13	$-.53
Diluted EPS	$-.15	$-.13	$-.53
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-37.28M	$-32.24M	$-118.84M
Operating Income / Loss	$-38.99M	$-33.42M	$-123.55M
Cost of Revenue
Net Cash Flow	$5.54M	$16.94M	$18.33M
PE Ratio

Splits
Apr 28, 2017	1:70
Apr 26, 2010	1:25
Jul 26, 2000	1:2